Topical metronidazole for the treatment of wound odor: a review of the literature
- PMID: 18382045
Topical metronidazole for the treatment of wound odor: a review of the literature
Abstract
Unpleasant odor is a frequent and distressing concern of persons who have wounds, as well as their family members and caregivers. In some instances, standard nursing interventions such as increasing the frequency of dressing changes will not be sufficient to address wound malodor. A review of the literature to summarize research findings about topical metronidazole used to decrease wound odor was conducted. Fifteen (15) studies were identified: seven case reports/series; six descriptive longitudinal studies; and two controlled clinical trials. Metronidazole was used as a 1% solution or, more frequently, as a 0.75% or 0.80% gel. Two reported adverse effects were skin irritation and a burning sensation. Generally, topical metronidazole was reported to result in a reduction or eradication of wound odor, decrease in wound drainage, improvement in wound appearance, decrease in surrounding cellulitis, halting of tissue necrosis, and decrease in pain. Although nurses report success with sprinkling crushed metronidazole pills on wounds, no published reports of this method of topical application are available. Topical metronidazole may be considered as an option for the management of malodorous wounds and additional randomized controlled trials with adequate sample sizes and comparison to products noted to decrease odor are warranted. While topical metronidazole for the treatment of malodorous wounds presently is off-label, perhaps such studies will result in the addition of malodorous wounds to the list of its indications.
Similar articles
-
A topical metronidazole gel used to treat malodorous wounds.Br J Nurs. 2004 Jun 10;13(11):S4-11. doi: 10.12968/bjon.2004.13.Sup2.13233. Br J Nurs. 2004. PMID: 15218439 Clinical Trial.
-
Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75 % gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013).Support Care Cancer. 2016 Jun;24(6):2583-90. doi: 10.1007/s00520-015-3067-0. Epub 2015 Dec 30. Support Care Cancer. 2016. PMID: 26715293 Free PMC article. Clinical Trial.
-
Topical Metronidazole for Odor Control in Pressure Ulcers.Consult Pharm. 2015 Sep;30(9):523-6. doi: 10.4140/TCP.n.2015.523. Consult Pharm. 2015. PMID: 26350892 Review.
-
Case study: eliminating odors from wounds.Decubitus. 1993 Jul;6(4):43-6. Decubitus. 1993. PMID: 8297491
-
Wound infection and colonisation.Nurs Stand. 2005 Feb 23-Mar 1;19(24):57-8, 60, 62 passim. doi: 10.7748/ns2005.02.19.24.57.c3812. Nurs Stand. 2005. PMID: 15754927 Review.
Cited by
-
The efficacy of a new paste formulation as an alternative therapeutic agent for traumatic ulcers.J Taibah Univ Med Sci. 2021 Jun 12;16(5):724-732. doi: 10.1016/j.jtumed.2021.05.005. eCollection 2021 Oct. J Taibah Univ Med Sci. 2021. PMID: 34690654 Free PMC article.
-
Healer Granules in Nonhealing Infected Wounds.Ann Maxillofac Surg. 2018 Jul-Dec;8(2):224-229. doi: 10.4103/ams.ams_35_18. Ann Maxillofac Surg. 2018. PMID: 30693236 Free PMC article.
-
Topical odour management in burn patients.Burns Trauma. 2021 Aug 26;9:tkab025. doi: 10.1093/burnst/tkab025. eCollection 2021. Burns Trauma. 2021. PMID: 34458382 Free PMC article.
-
A Comprehensive Review of Topical Odor-Controlling Treatment Options for Chronic Wounds.J Wound Ostomy Continence Nurs. 2016 Nov/Dec;43(6):598-609. doi: 10.1097/WON.0000000000000273. J Wound Ostomy Continence Nurs. 2016. PMID: 27684356 Free PMC article. Review.
-
Development of 3D-Printed Hydrogel Disks as Standardized Platform for Evaluating Excipient Impact on Metronidazole's Antimicrobial Activity.Pharmaceutics. 2025 Jun 6;17(6):749. doi: 10.3390/pharmaceutics17060749. Pharmaceutics. 2025. PMID: 40574061 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources